BR0210798A - vacinas de mycoplasma bovis e métodos de redução de pneumonia em animais - Google Patents
vacinas de mycoplasma bovis e métodos de redução de pneumonia em animaisInfo
- Publication number
- BR0210798A BR0210798A BRPI0210798-8A BR0210798A BR0210798A BR 0210798 A BR0210798 A BR 0210798A BR 0210798 A BR0210798 A BR 0210798A BR 0210798 A BR0210798 A BR 0210798A
- Authority
- BR
- Brazil
- Prior art keywords
- mycoplasma bovis
- vaccine
- methods
- vaccines
- animals
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
- A61K39/0241—Mollicutes, e.g. Mycoplasma, Erysipelothrix
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N1/00—Microorganisms; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
- C12N1/36—Adaptation or attenuation of cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/52—Bacterial cells; Fungal cells; Protozoal cells
- A61K2039/521—Bacterial cells; Fungal cells; Protozoal cells inactivated (killed)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
- A61K2039/552—Veterinary vaccine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55511—Organic adjuvants
- A61K2039/55577—Saponins; Quil A; QS21; ISCOMS
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- Microbiology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biotechnology (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Genetics & Genomics (AREA)
- Mycology (AREA)
- Immunology (AREA)
- Epidemiology (AREA)
- Virology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Tropical Medicine & Parasitology (AREA)
- Communicable Diseases (AREA)
- Biomedical Technology (AREA)
- Oncology (AREA)
- Cell Biology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Biochemistry (AREA)
- General Engineering & Computer Science (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US30263801P | 2001-07-02 | 2001-07-02 | |
| PCT/IB2002/002514 WO2003004052A1 (en) | 2001-07-02 | 2002-06-27 | Mycoplasma bovis vaccine and methods of reducing pneumonia in animals |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BR0210798A true BR0210798A (pt) | 2006-05-23 |
Family
ID=23168600
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BRPI0210798-8A BR0210798A (pt) | 2001-07-02 | 2002-06-27 | vacinas de mycoplasma bovis e métodos de redução de pneumonia em animais |
Country Status (31)
| Country | Link |
|---|---|
| US (1) | US20030147914A1 (https=) |
| EP (1) | EP1401488A1 (https=) |
| JP (1) | JP2004536106A (https=) |
| KR (1) | KR20040030783A (https=) |
| CN (1) | CN1522152A (https=) |
| AP (1) | AP2002002568A0 (https=) |
| AR (1) | AR036125A1 (https=) |
| BG (1) | BG108496A (https=) |
| BR (1) | BR0210798A (https=) |
| CA (1) | CA2452580A1 (https=) |
| CZ (1) | CZ20033465A3 (https=) |
| EA (1) | EA200301324A1 (https=) |
| GT (1) | GT200200139A (https=) |
| HN (1) | HN2002000162A (https=) |
| HR (1) | HRP20031078A2 (https=) |
| HU (1) | HUP0501188A2 (https=) |
| IL (1) | IL159516A0 (https=) |
| IS (1) | IS7078A (https=) |
| MA (1) | MA27048A1 (https=) |
| MX (1) | MXPA03011815A (https=) |
| NO (1) | NO20035767L (https=) |
| OA (1) | OA12640A (https=) |
| PA (1) | PA8549801A1 (https=) |
| PE (1) | PE20030239A1 (https=) |
| PL (1) | PL373891A1 (https=) |
| SK (1) | SK15802003A3 (https=) |
| TN (1) | TNSN03154A1 (https=) |
| UY (1) | UY27365A1 (https=) |
| WO (1) | WO2003004052A1 (https=) |
| YU (1) | YU102103A (https=) |
| ZA (1) | ZA200309747B (https=) |
Families Citing this family (26)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7179473B2 (en) | 1998-06-05 | 2007-02-20 | Boehringer Ingelheim Vetmedica Gmbh | Attenuated pestiviruses |
| US7135561B2 (en) | 2001-09-06 | 2006-11-14 | Boehringer Ingelheim Vetmedica Gmbh | Infectious bovine viral diarrhea virus clone |
| US7279166B2 (en) * | 2001-12-12 | 2007-10-09 | Virginia Tech Intellectual Properties, Inc. | Chimeric infectious DNA clones, chimeric porcine circoviruses and uses thereof |
| SE0301436D0 (sv) * | 2003-05-16 | 2003-05-16 | Joakim Westberg | New proteins |
| US7572455B2 (en) * | 2004-05-19 | 2009-08-11 | Boehringer Ingelheim Vetmedica Gmbh | Vaccine comprising an attenuated pestivirus |
| US20090068223A1 (en) * | 2005-11-15 | 2009-03-12 | Boehringer Ingelheim Vetmedica, Inc. | Combination vaccine comprising an attenuated bovine viral diarrhea virus |
| WO2008030619A2 (en) * | 2006-09-07 | 2008-03-13 | Boehringer Ingelheim Vetmedica, Inc. | Pcr-based genotyping |
| EP2066340B1 (en) | 2006-09-11 | 2013-07-31 | Zoetis P LLC | Heat treated bacterins, and emulsion vaccines prepared from such heat treated bacterins |
| AR069087A1 (es) * | 2007-10-29 | 2009-12-30 | Boehringer Ingelheim Vetmed | Cepa bacteriana de m. bovis atenuada avirulenta obtenida por pases, vacuna de micoplasma boris y metodos de uso de la misma |
| UY31930A (es) * | 2008-06-25 | 2010-01-29 | Boheringer Ingelheim Pharma Kg | Pestivirus atenuados recombinantes, en particular a csfv, bvdv o bdv atenuado recombinante |
| EP2320943B1 (en) * | 2008-07-03 | 2016-02-17 | Iowa State University Research Foundation, Inc. | Cattle vaccines |
| MX2011004316A (es) * | 2008-10-31 | 2011-06-16 | Boehringer Ingelheim Vetmed | Uso de antigenos diversos que incluyen antigenos de mycoplasma bovis en composicion de vacuna multivalente. |
| US8846054B2 (en) * | 2009-01-09 | 2014-09-30 | Boehringer Ingelheim Vetmedica, Inc. | Method of treating pregnant cows and/or heifers |
| UY32570A (es) * | 2009-04-24 | 2010-11-30 | Boehringer Ingelheim Vetmed | Vacuna viva modificada de mycoplasma bovis mejorada |
| KR101795524B1 (ko) | 2009-06-04 | 2017-11-08 | 고쿠리츠칸센쇼켄쿠죠 | 마이코플라즈마 감염증용 백신 |
| CN102220263B (zh) * | 2011-05-06 | 2012-10-03 | 华中农业大学 | 一种牛支原体致弱菌株及其应用 |
| PT2938747T (pt) | 2012-12-28 | 2019-08-01 | Boehringer Ingelheim Vetmedica Gmbh | Método de preparação de uma vacina de micoplasma |
| CN104857509A (zh) * | 2015-06-02 | 2015-08-26 | 福清市默克兽医院 | 牛支原体肺炎组织灭活疫苗的制备方法、配方及使用方法 |
| CA2995101A1 (en) | 2015-08-14 | 2017-02-23 | Zoetis Services Llc | Mycoplasma bovis compositions |
| CN105441368B (zh) * | 2016-01-19 | 2019-01-01 | 福清市默克兽医院 | 一株牛支原体及其应用 |
| CN106929452B (zh) * | 2017-04-11 | 2020-06-12 | 河南省农业科学院畜牧兽医研究所 | 一株牛支原体及其应用 |
| CN109022314B (zh) * | 2018-08-06 | 2021-08-13 | 北京华夏兴洋生物科技有限公司 | 一株牛支原体及其在疫苗研制中的应用 |
| CN110338138B (zh) * | 2019-06-19 | 2021-04-06 | 山东省农业科学院奶牛研究中心 | 一种牛支原体感染豚鼠的动物模型构建方法及其应用 |
| CN112301041B (zh) * | 2020-10-09 | 2022-05-24 | 华中农业大学 | 牛支原体p21蛋白及其应用 |
| CN113546162B (zh) * | 2021-05-31 | 2023-07-18 | 江苏省农业科学院 | 一种支原体疫苗及其制备方法 |
| CN113604492B (zh) * | 2021-09-10 | 2023-07-07 | 苏州世诺生物技术有限公司 | 融合基因、融合蛋白及制备方法和牛支原体亚单位疫苗 |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5565205A (en) * | 1990-08-16 | 1996-10-15 | Solvay Animal Health, Inc. | Inactivated Mycoplasma hypopneumoniae bacterin and method of use thereof |
| BR0015398A (pt) * | 1999-11-08 | 2002-06-25 | Biomune | Vacinas para mycoplasma bovis e processos de uso |
| DE29921392U1 (de) * | 1999-12-06 | 2000-03-16 | Dr. Felgenträger & Co. Öko-Chem. und Pharma GmbH, 06862 Rodleben | Mykoplasma-bovis-Kombinations-Vakzine für Rinder |
| US6548069B2 (en) * | 2001-02-03 | 2003-04-15 | Hmv Associates, Inc. | Multivalent Mycoplasma bacterin |
-
2002
- 2002-06-20 US US10/177,857 patent/US20030147914A1/en not_active Abandoned
- 2002-06-27 KR KR10-2004-7000003A patent/KR20040030783A/ko not_active Ceased
- 2002-06-27 BR BRPI0210798-8A patent/BR0210798A/pt not_active IP Right Cessation
- 2002-06-27 EP EP02738544A patent/EP1401488A1/en not_active Withdrawn
- 2002-06-27 PL PL02373891A patent/PL373891A1/xx unknown
- 2002-06-27 JP JP2003510062A patent/JP2004536106A/ja active Pending
- 2002-06-27 YU YU102103A patent/YU102103A/sh unknown
- 2002-06-27 EA EA200301324A patent/EA200301324A1/ru unknown
- 2002-06-27 MX MXPA03011815A patent/MXPA03011815A/es unknown
- 2002-06-27 TN TNPCT/IB2002/002514A patent/TNSN03154A1/fr unknown
- 2002-06-27 CN CNA028132882A patent/CN1522152A/zh active Pending
- 2002-06-27 SK SK1580-2003A patent/SK15802003A3/sk not_active Application Discontinuation
- 2002-06-27 HU HU0501188A patent/HUP0501188A2/hu unknown
- 2002-06-27 IL IL15951602A patent/IL159516A0/xx unknown
- 2002-06-27 HR HR20031078A patent/HRP20031078A2/hr not_active Application Discontinuation
- 2002-06-27 OA OA1200300346A patent/OA12640A/en unknown
- 2002-06-27 AP APAP/P/2002/002568A patent/AP2002002568A0/en unknown
- 2002-06-27 CA CA002452580A patent/CA2452580A1/en not_active Abandoned
- 2002-06-27 CZ CZ20033465A patent/CZ20033465A3/cs unknown
- 2002-06-27 WO PCT/IB2002/002514 patent/WO2003004052A1/en not_active Ceased
- 2002-06-28 HN HN2002000162A patent/HN2002000162A/es unknown
- 2002-07-01 AR ARP020102480A patent/AR036125A1/es unknown
- 2002-07-01 PE PE2002000592A patent/PE20030239A1/es not_active Application Discontinuation
- 2002-07-01 UY UY27365A patent/UY27365A1/es not_active Application Discontinuation
- 2002-07-02 PA PA20028549801A patent/PA8549801A1/es unknown
- 2002-07-02 GT GT200200139A patent/GT200200139A/es unknown
-
2003
- 2003-12-15 IS IS7078A patent/IS7078A/is unknown
- 2003-12-17 ZA ZA200309747A patent/ZA200309747B/xx unknown
- 2003-12-22 NO NO20035767A patent/NO20035767L/no not_active Application Discontinuation
- 2003-12-22 BG BG108496A patent/BG108496A/xx unknown
- 2003-12-31 MA MA27469A patent/MA27048A1/fr unknown
Also Published As
| Publication number | Publication date |
|---|---|
| CA2452580A1 (en) | 2003-01-16 |
| HRP20031078A2 (en) | 2005-08-31 |
| BG108496A (en) | 2005-02-28 |
| YU102103A (sh) | 2006-05-25 |
| KR20040030783A (ko) | 2004-04-09 |
| PE20030239A1 (es) | 2003-03-21 |
| UY27365A1 (es) | 2003-04-30 |
| EP1401488A1 (en) | 2004-03-31 |
| NO20035767L (no) | 2004-01-30 |
| AP2002002568A0 (en) | 2002-06-30 |
| IL159516A0 (en) | 2004-06-01 |
| PA8549801A1 (es) | 2003-09-17 |
| AR036125A1 (es) | 2004-08-11 |
| MA27048A1 (fr) | 2004-12-20 |
| JP2004536106A (ja) | 2004-12-02 |
| TNSN03154A1 (fr) | 2005-12-23 |
| WO2003004052A1 (en) | 2003-01-16 |
| GT200200139A (es) | 2003-02-13 |
| IS7078A (is) | 2003-12-15 |
| US20030147914A1 (en) | 2003-08-07 |
| CZ20033465A3 (cs) | 2004-12-15 |
| SK15802003A3 (sk) | 2005-01-03 |
| OA12640A (en) | 2006-06-15 |
| PL373891A1 (en) | 2005-09-19 |
| HN2002000162A (es) | 2002-09-17 |
| CN1522152A (zh) | 2004-08-18 |
| ZA200309747B (en) | 2005-05-27 |
| MXPA03011815A (es) | 2004-04-02 |
| EA200301324A1 (ru) | 2004-12-30 |
| HUP0501188A2 (en) | 2006-05-29 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| BR0210798A (pt) | vacinas de mycoplasma bovis e métodos de redução de pneumonia em animais | |
| WO2003004051A3 (en) | Mycoplasma hyopneumoniae vaccine and methods for reducing mycoplasma bovis pneumonia in cattle | |
| BR0210804A (pt) | Vacinação de dose única com mycoplásma hyopneumoniae | |
| BR9909483A (pt) | Derivados de proteìnas ligantes pneumococcal colina para vacinas | |
| BRPI0010612B8 (pt) | vacinas | |
| BR0212999A (pt) | novas composições imunogênicas para a prevenção e tratamento de doença meningocócica | |
| BR0007166A (pt) | Método para aumentar a atividade dos animais de estimação | |
| BRPI0614119B8 (pt) | vacina para imunizar gatos contra calicivírus de felino | |
| BRPI0419273A (pt) | composições e métodos para tratar infecções microbianas e parasìticas em gado vacum e outros animais | |
| PT777499E (pt) | Vacina viva para tratamento de doencas tumorais | |
| BR0109928A (pt) | Uso de um herpes vìrus atenuado, e, método para estimular uma resposta imune em um indivìduo humano ou animal, ou para tratar ou prevenir uma infecção patogênica ou câncer em um indivìduo humano ou animal | |
| AR036355A1 (es) | Modelo de exposicion a mycoplasma bovis, para evaluar la eficacia de potenciales vacunas | |
| US7910620B2 (en) | Uses of neuraminidase inhibitors in infectious diseases | |
| AR048671A1 (es) | Procedimiento de vacunacion contra la infeccion testicular por bvdv | |
| WO2012042857A1 (ja) | 粘膜アジュバント組成物 | |
| CY1116862T1 (el) | Εμβολιασμος μιας δοσης me mycoplasma hyopneumoniae | |
| RU2230505C2 (ru) | Способ профилактики туберкулеза крупного рогатого скота | |
| Govinder et al. | Kausar Qadri and HK Mehta | |
| Rao | Prevalence, treatment and control of haemorrhagic septicaemia in sheep. | |
| Abidin | promoting infection | |
| Gordon | Clinical Forum: Calf pneumonia | |
| Shewen | Department of Veterinary Microbiology and Immunology Ontario Veterinary College University of Guelph Guelph, Canada N1G 2W1 | |
| US20160235703A1 (en) | Novel Uses of Neuraminidase Inhibitors in Infectious Diseases | |
| BR0314668A (pt) | Utilização de excipientes para aumentar a captação de dna por células musculares de suìno | |
| BRPI0415626A (pt) | vacina de erysipelothrix rhusiopathiae - haemophilus parasuis e métodos de empregar a mesma |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| B08F | Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette] |
Free format text: REFERENTE A 7A E 8A ANUIDADES. |
|
| B08K | Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette] |
Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 2060 DE 29/06/2010. |